These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 315164

  • 1. Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia.
    McGrath KM, Johnson CA, Stuart JJ.
    Am J Med; 1979 Oct; 67(4):693-6. PubMed ID: 315164
    [Abstract] [Full Text] [Related]

  • 2. Platelet-collagen interactions: increase in rate of adhesion of fixed washed platelets by factor VIII-related antigen.
    Aihara M, Cooper HA, Wagner RH.
    Blood; 1984 Mar; 63(3):495-501. PubMed ID: 6421343
    [Abstract] [Full Text] [Related]

  • 3. Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.
    Meyer D, Frommel D, Larrieu MJ, Zimmerman TS.
    Blood; 1979 Sep; 54(3):600-6. PubMed ID: 313821
    [Abstract] [Full Text] [Related]

  • 4. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.
    Mohri H, Noguchi T, Kodama F, Itoh A, Ohkubo T.
    Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370
    [Abstract] [Full Text] [Related]

  • 5. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J, Lillicrap DP, Izaguirre CA, Sutherland M, Windsor S, Benford K, Hoogendorn H, Giles AR.
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of antibody-induced acquired von Willebrand Syndrome.
    Gan TE, Sawers RJ, Koutts J.
    Am J Hematol; 1980 Oct; 9(4):363-71. PubMed ID: 6782864
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies to human FVIIIR:Ag and FVIIIC.
    Francis SE, Joshua DE, Exner T, Kronenberg H.
    Pathology; 1985 Oct; 17(4):579-85. PubMed ID: 2419825
    [Abstract] [Full Text] [Related]

  • 8. [4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia].
    Horellou MH, Baumelou E, Sitbon N, Marie JP, Conard J, De Carbonnières C, Gorin NC, Zittoun R, Samama M.
    Ann Med Interne (Paris); 1983 Oct; 134(8):707-12. PubMed ID: 6421219
    [Abstract] [Full Text] [Related]

  • 9. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A, Miller JL, Neuberg RW, Gawryl MS, Hoyer LW.
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [Abstract] [Full Text] [Related]

  • 10. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M, Kimura A, Chiba Y, Yoshida Y.
    Thromb Haemost; 1988 Jun 16; 59(3):485-90. PubMed ID: 3142084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factor VIIIR:Ag plasma levels in patients with cervical and ovarian carcinoma.
    Facchini V, Gadducci A, Baicchi U, Del Bravo B, Vispi M, Teti G, Fioretti P.
    Eur J Gynaecol Oncol; 1988 Jun 16; 9(1):87-93. PubMed ID: 3126071
    [Abstract] [Full Text] [Related]

  • 13. Telangiectasia and von Willebrand's disease in two families.
    Conlon CL, Weinger RS, Cimo PL, Moake JL, Olson JD.
    Ann Intern Med; 1978 Dec 16; 89(6):921-4. PubMed ID: 309746
    [Abstract] [Full Text] [Related]

  • 14. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.
    Mohri H, Ohkubo T.
    Acta Haematol; 1987 Dec 16; 78(4):258-64. PubMed ID: 3122493
    [Abstract] [Full Text] [Related]

  • 15. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 16; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 16. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG, Ershler WB, Golden EA, Tindle BH, Edson JR.
    Am J Clin Pathol; 1986 Jan 16; 85(1):115-23. PubMed ID: 3079626
    [Abstract] [Full Text] [Related]

  • 17. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 18. Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens.
    Lazarchick J, Pappas AA, Kizer J, Hall SA.
    Am J Hematol; 1986 Mar 11; 21(3):305-14. PubMed ID: 3080872
    [Abstract] [Full Text] [Related]

  • 19. Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.
    Blatt PM, Brinkhous KM, Culp HR, Krauss JS, Roberts HR.
    JAMA; 1976 Dec 13; 236(24):2770-2. PubMed ID: 1086910
    [Abstract] [Full Text] [Related]

  • 20. Studies on the haemostatic system in peripheral arterial disease. 2. Variations in factor VIII components (FVIII:C ; FVIIIR:Ag ; FVIII:WF) before and after venous occlusion.
    Dettori AG, Pini M, Megha A, Portioli D, Ponari O.
    Thromb Res; 1976 Dec 13; 22(5-6):559-64. PubMed ID: 6795750
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.